Stay updated on EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer

Sign up to get notified when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.
Latest website image capture
Clouds background image

Latest updates to the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page

  1. Check
    today
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating a site or release maintenance update rather than a change to the study record.
    Difference
    0.0%
    Check dated 2026-04-25T05:27:56.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T03:29:58.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 and removed Napoli, Italy, 80131 from the study locations.
    Difference
    0.0%
    Check dated 2026-03-27T12:32:18.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T03:48:38.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:42:17.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Version update from v3.4.1 to v3.4.2 was deployed; no user-visible changes to study data or navigation are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:15:32.000Z thumbnail image

Stay in the know with updates to EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer

Enter your email address, and we'll notify you when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.